The Indian rupee recovered from initial losses to close 24 paise higher at 95.46 against the US dollar on Tuesday. The currency was supported by positive domestic equity markets, a weaker dollar index, and declining crude oil prices.

The Indian rupee pared its initial losses and settled for the day higher by 24 paise at 95.46 (provisional) against the US dollar on Tuesday. Market participants noted that the recovery was driven by positive domestic markets, a weaker greenback, and a fall in crude oil prices.

At the interbank foreign exchange market, the rupee opened at 95.74. During the session, it touched an intraday high of 95.40 before finally settling at 95.46 against the greenback, marking a 24-paise gain from its previous close. On Monday, the currency had settled with a marginal gain of 1 paisa at 95.70 against the US dollar.

Forex traders indicated that overall weakness in the US dollar, stemming from declining odds of an interest rate hike, may continue to support the rupee at lower levels. The USD/INR pair remained largely range-bound around the 95.50–96.00 band. Oil prices and upcoming interventions by the Reserve Bank of India are expected to remain key near-term drivers for the currency.

Externally, the dollar index—which measures the strength of the greenback against a basket of six major currencies—was trading lower by 0.04 percent at 98.96. Meanwhile, Brent crude, the global benchmark for oil, traded lower by 2.99 percent at $89.41 per barrel in futures trade.

On the domestic market front, equity indices posted gains. The Sensex climbed 286.98 points to settle at 77,656.09, while the Nifty advanced 115.50 points to end the session at 24,334.55. Exchange data showed that foreign institutional investors purchased equities worth ₹1,181.66 crore on a net basis on Monday.

On the macroeconomic front, data from the Reserve Bank of India indicated that its special USD-INR forex swap facility for FCNR(B) deposits, Overseas Foreign Currency Borrowings, and External Commercial Borrowings has mobilized foreign exchange inflows of $73 billion as of August 21, 2026. This reflects strong backing and participation from Non-Resident Indians.

"Fluctuations in the foreign exchange market have a direct impact on corporate planning, import costs, and overall macroeconomic stability in the country. The recent resilience shown by the rupee, supported by falling crude prices and strong foreign exchange inflows through RBI facilities, provides a stable environment for businesses operating in domestic and international markets. Founders and business leaders must continue to monitor currency trends closely while managing their cross-border transactions and financial liabilities." — Dr. Shishir Gupta, Founder & CEO, StartupLanes

Recent StartupLanes Articles

Browse through our 30 latest publications on venture capital, startups, and angel investing.

OpenAI Acquires Orchestra Bio to Expand Life Sciences and Drug Development Capabilities Oct 22, 2026
Dr. Reddy’s Laboratories Receives DCGI Approval for Toripalimab in India Oct 22, 2026
Anthropic's Confidential IPO Filing Reveals $80.7 Billion H1 Loss and Heavy Computing Costs Oct 22, 2026
Jio Platforms Launches ₹30,213 Crore IPO: Key Details, Valuations, and Brokerage Views Oct 22, 2026
State Bank of India Reports Suspected Customer Data Exposure on Dark Web Oct 22, 2026
US Secretary of State Marco Rubio Terms Envoy Meeting with Ukrainian President Positive Oct 22, 2026
Rupee Strengthens 29 Paise Against US Dollar in Early Trade, Supported by RBI and Jio IPO Inflows Oct 22, 2026
Brent Crude Stays Above $110 Amid West Asia Supply Concerns and Inventory Data Oct 22, 2026
Indian Market Updates: Corporate Earnings, Strategic Agreements, and Expansion Plans Across Sectors Oct 22, 2026
Corporate Updates: Infosys Expands Truist Collaboration, Cemindia Raises ₹1,400 Crore via QIP, and Multiple Firms Report Contracts and Acquisitions Oct 22, 2026
Centre to Review National Mineral Policy 2019 to Focus on Critical Minerals and Deep-Sea Resources Oct 22, 2026
Qualcomm Announces Global Job Cuts Following Annual Performance Reviews Oct 22, 2026
AstraZeneca Pharma Relocates Registered Office from Karnataka to Maharashtra Oct 22, 2026
Hindusthan National Glass Plans Up to ₹500 Crore Investment to Scale Manufacturing Capacity Oct 21, 2026
FSSAI Directs Nutraceutical Makers to Ensure Mandatory Warning Labels on Botanical Products Oct 21, 2026